Urology Times January 2, 2024
Jason M. Broderick

This year, the FDA authorized a multitude of new treatments and devices for use in urology practice. Here are the highlights.

February

LithoVue Elite System for ureteroscopy

The FDA granted 510(k) clearance to the LithoVue Elite Single-Use Digital Flexible Ureteroscope System.1 The device is the first of its kind, with the ability to monitor intrarenal pressure (IRP) in real time during ureteroscopy procedures to manage kidney stones, according to Boston Scientific Corporation. The LithoVue system includes a built-in pressure sensor on the tip of the ureteroscope to help urologists make informed clinical decisions during ureteroscopies, where fluid irrigation intended to provide a clear visual field can lead to elevated IRP.

March

New Illuccix indication for metastatic prostate cancer

The FDA...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Provider
From caregivers to collectors: Navigating the new landscape of patient payments
Yonsei University opens medical robot training centre and more briefs
MHE Week in Review – New PBM Reform Bill, Cardiac Diseases Cost
People Are Getting Brain Implants For BCI
Digital mental health programs are inexpensive and innovative. But do they work?

Share This Article